SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-21-005363
Filing Date
2021-03-23
Accepted
2021-03-23 16:16:07
Documents
6
Effectiveness Date
2021-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 a032021s-8.htm S-8 94692
2 EX-5.1 x4-sx8x51opinionmarch2021.htm EX-5.1 14672
3 EX-23.1 pricewaterhousecooperscons.htm EX-23.1 2025
4 image_11.jpg GRAPHIC 8359
5 image_21.jpg GRAPHIC 173
6 image_31.jpg GRAPHIC 1810
  Complete submission text file 0001628280-21-005363.txt   126917
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254618 | Film No.: 21764972
SIC: 2836 Biological Products, (No Diagnostic Substances)